This suggests that the more patient-friendly monitoring of patients on the basis of peripheral blood is probably accurate32, comparable with the monitoring of BCR-ABL levels in peripheral blood of chronic myeloid leukaemia patients33. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.